by 
Cell culture involves growing living cells outside their natural environment in specially-designed containers called bioreactors. It is widely used in biotechnology and medicinal applications, primarily related to the production of therapeutic proteins and vaccines. Cell culture products include various media and reagents that play a vital role in supporting optimal cell growth as well as maintaining cell viability. Media provides nutrients to sustain cell growth and supplements enable them to thrive through various metabolic processes. Growing demand for medical therapies such as monoclonal antibodies, vaccines, and regenerative medicines have propelled the development and commercialization of cell culture technologies worldwide.
The global cell culture market size is estimated to be valued at US$ 19,198.0 Mn in 2024 and is expected to exhibit a CAGR of 7.2% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends
One of the key trends in the cell culture market is the shift towards 3D cell culture systems. Three-dimensional (3D) cell culture models that better mimic in vivo environments compared to traditional 2D models are gaining ground. 3D systems allow for cell-cell and cell-matrix interactions which facilitate improved physiological relevance. This enables more accurate predictive analyses for drug discovery and development. Major players are actively investing in 3D bioprinting and scaffold-based 3D culture technologies to overcome current limitations of 2D platforms. Another important trend is the customization of cell culture media formulations. Market participants are developing customized media blends tailored to specific cell types and applications. This provides enhanced control over experimental conditions and cell behavior. Customized solutions also help reduce wastage and optimize resource utilization compared to conventional “one size fits all” products.
Porter’s Analysis
Threat of new entrants: Low capital requirements and lack of proprietary technologies pose a low threat of new entrants. However, stringent regulations and high R&D costs act as barriers for new players.
Bargaining power of buyers: Buyers have moderate bargaining power due to availability of substitutes and significance of innovations.
Bargaining power of suppliers: Suppliers have moderate-to-high bargaining power due to necessity of raw materials and lack of substitutes.
Threat of new substitutes: Threat of substitutes is low as cell culture process involves complex techniques with no close substitutes available.
Competitive rivalry: Intense competitive rivalry exists among existing players to gain market share through product development, mergers & acquisitions, and expansion to new regions.
Key Takeaways
The global cell culture market is expected to witness high growth. The global cell culture market size is estimated to be valued at US$ 19,198.0 Mn in 2024 and is expected to exhibit a CAGR of 7.2% over the forecast period 2023 to 2030.
Regional analysis
The cell culture market in North America is dominating with the largest share due to presence of major market players and advanced healthcare facilities. The Asia Pacific region is projected to witness the highest growth rate during the forecast period. This growth can be attributed to factors such as rising healthcare investments, increasing biomedical research, and growing outsourcing activities by major players towards the developing nations in Asia.
Key players
Key players operating in the cell culture market are Corning Incorporated, Merck KGaA, Sartorius AG, BioSpherix, Ltd., Cell Culture Company, LLC, Thermo Fisher Scientific Inc., VWR International LLC, and Lonza. Corning Incorporated and Thermo Fisher Scientific Inc. collectively hold a majority market share. Players are focusing on new product launches and expansions to strengthen their market position.
*Note:
- Source: Coherent Market Insights, Public sources, Desk research
- We have leveraged AI tools to mine information and compile it
